Cargando…
Challenges in the Development of an Immunochromatographic Interferon-Gamma Test for Diagnosis of Pleural Tuberculosis
Existing diagnostic tests for pleural tuberculosis (TB) have inadequate accuracy and/or turnaround time. Interferon-gamma (IFNg) has been identified in many studies as a biomarker for pleural TB. Our objective was to develop a lateral flow, immunochromatographic test (ICT) based on this biomarker an...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871622/ https://www.ncbi.nlm.nih.gov/pubmed/24376880 http://dx.doi.org/10.1371/journal.pone.0085447 |
_version_ | 1782296849097424896 |
---|---|
author | Denkinger, Claudia M. Kalantri, Yatiraj Schumacher, Samuel G. Michael, Joy S. Shankar, Deepa Saxena, Arvind Sriram, Natarajan Balamugesh, Thangakunam Luo, Robert Pollock, Nira R. Pai, Madhukar Christopher, Devasahayam J. |
author_facet | Denkinger, Claudia M. Kalantri, Yatiraj Schumacher, Samuel G. Michael, Joy S. Shankar, Deepa Saxena, Arvind Sriram, Natarajan Balamugesh, Thangakunam Luo, Robert Pollock, Nira R. Pai, Madhukar Christopher, Devasahayam J. |
author_sort | Denkinger, Claudia M. |
collection | PubMed |
description | Existing diagnostic tests for pleural tuberculosis (TB) have inadequate accuracy and/or turnaround time. Interferon-gamma (IFNg) has been identified in many studies as a biomarker for pleural TB. Our objective was to develop a lateral flow, immunochromatographic test (ICT) based on this biomarker and to evaluate the test in a clinical cohort. Because IFNg is commonly present in non-TB pleural effusions in low amounts, a diagnostic IFNg-threshold was first defined with an enzyme-linked immunosorbent assay (ELISA) for IFNg in samples from 38 patients with a confirmed clinical diagnosis (cut-off of 300pg/ml; 94% sensitivity and 93% specificity). The ICT was then designed; however, its achievable limit of detection (5000pg/ml) was over 10-fold higher than that of the ELISA. After several iterations in development, the prototype ICT assay for IFNg had a sensitivity of 69% (95% confidence interval (CI): 50-83) and a specificity of 94% (95% CI: 81-99%) compared to ELISA on frozen samples. Evaluation of the prototype in a prospective clinical cohort (72 patients) on fresh pleural fluid samples, in comparison to a composite reference standard (including histopathological and microbiologic test results), showed that the prototype had 65% sensitivity (95% CI: 44-83) and 89% specificity (95% CI: 74-97). Discordant results were observed in 15% of samples if testing was repeated after one freezing and thawing step. Inter-rater variability was limited (3%; 1out of 32). In conclusion, despite an iterative development and optimization process, the performance of the IFNg ICT remained lower than what could be expected from the published literature on IFNg as a biomarker in pleural fluid. Further improvements in the limit of detection of an ICT for IFNg, and possibly combination of IFNg with other biomarkers such as adenosine deaminase, are necessary for such a test to be of value in the evaluation of pleural tuberculosis. |
format | Online Article Text |
id | pubmed-3871622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38716222013-12-27 Challenges in the Development of an Immunochromatographic Interferon-Gamma Test for Diagnosis of Pleural Tuberculosis Denkinger, Claudia M. Kalantri, Yatiraj Schumacher, Samuel G. Michael, Joy S. Shankar, Deepa Saxena, Arvind Sriram, Natarajan Balamugesh, Thangakunam Luo, Robert Pollock, Nira R. Pai, Madhukar Christopher, Devasahayam J. PLoS One Research Article Existing diagnostic tests for pleural tuberculosis (TB) have inadequate accuracy and/or turnaround time. Interferon-gamma (IFNg) has been identified in many studies as a biomarker for pleural TB. Our objective was to develop a lateral flow, immunochromatographic test (ICT) based on this biomarker and to evaluate the test in a clinical cohort. Because IFNg is commonly present in non-TB pleural effusions in low amounts, a diagnostic IFNg-threshold was first defined with an enzyme-linked immunosorbent assay (ELISA) for IFNg in samples from 38 patients with a confirmed clinical diagnosis (cut-off of 300pg/ml; 94% sensitivity and 93% specificity). The ICT was then designed; however, its achievable limit of detection (5000pg/ml) was over 10-fold higher than that of the ELISA. After several iterations in development, the prototype ICT assay for IFNg had a sensitivity of 69% (95% confidence interval (CI): 50-83) and a specificity of 94% (95% CI: 81-99%) compared to ELISA on frozen samples. Evaluation of the prototype in a prospective clinical cohort (72 patients) on fresh pleural fluid samples, in comparison to a composite reference standard (including histopathological and microbiologic test results), showed that the prototype had 65% sensitivity (95% CI: 44-83) and 89% specificity (95% CI: 74-97). Discordant results were observed in 15% of samples if testing was repeated after one freezing and thawing step. Inter-rater variability was limited (3%; 1out of 32). In conclusion, despite an iterative development and optimization process, the performance of the IFNg ICT remained lower than what could be expected from the published literature on IFNg as a biomarker in pleural fluid. Further improvements in the limit of detection of an ICT for IFNg, and possibly combination of IFNg with other biomarkers such as adenosine deaminase, are necessary for such a test to be of value in the evaluation of pleural tuberculosis. Public Library of Science 2013-12-23 /pmc/articles/PMC3871622/ /pubmed/24376880 http://dx.doi.org/10.1371/journal.pone.0085447 Text en © 2013 Denkinger et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Denkinger, Claudia M. Kalantri, Yatiraj Schumacher, Samuel G. Michael, Joy S. Shankar, Deepa Saxena, Arvind Sriram, Natarajan Balamugesh, Thangakunam Luo, Robert Pollock, Nira R. Pai, Madhukar Christopher, Devasahayam J. Challenges in the Development of an Immunochromatographic Interferon-Gamma Test for Diagnosis of Pleural Tuberculosis |
title | Challenges in the Development of an Immunochromatographic Interferon-Gamma Test for Diagnosis of Pleural Tuberculosis |
title_full | Challenges in the Development of an Immunochromatographic Interferon-Gamma Test for Diagnosis of Pleural Tuberculosis |
title_fullStr | Challenges in the Development of an Immunochromatographic Interferon-Gamma Test for Diagnosis of Pleural Tuberculosis |
title_full_unstemmed | Challenges in the Development of an Immunochromatographic Interferon-Gamma Test for Diagnosis of Pleural Tuberculosis |
title_short | Challenges in the Development of an Immunochromatographic Interferon-Gamma Test for Diagnosis of Pleural Tuberculosis |
title_sort | challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871622/ https://www.ncbi.nlm.nih.gov/pubmed/24376880 http://dx.doi.org/10.1371/journal.pone.0085447 |
work_keys_str_mv | AT denkingerclaudiam challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT kalantriyatiraj challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT schumachersamuelg challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT michaeljoys challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT shankardeepa challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT saxenaarvind challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT sriramnatarajan challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT balamugeshthangakunam challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT luorobert challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT pollocknirar challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT paimadhukar challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis AT christopherdevasahayamj challengesinthedevelopmentofanimmunochromatographicinterferongammatestfordiagnosisofpleuraltuberculosis |